{
  "ticker": "PME.AX",
  "company": "Pro Medicus",
  "sector": "Healthcare IT",
  "market_cap": null,
  "hypotheses": {
    "N1": {
      "label": "US Expansion Accelerates",
      "description": "Pro Medicus executes on growth strategy; earnings accelerate",
      "plain_english": "This is the bull case — Pro Medicus delivers on its key initiatives and the market rewards it.",
      "what_to_watch": "Next earnings result and forward guidance.",
      "upside": "Material re-rating if execution surprises to the upside.",
      "risk_plain": "If growth disappoints, this narrative weakens.",
      "survival_score": 0.5,
      "status": "MODERATE",
      "weighted_inconsistency": 3,
      "last_updated": "2026-02-16T06:49:06.276Z"
    },
    "N2": {
      "label": "Valuation Mean-Reversion",
      "description": "Pro Medicus delivers steady-state results; valuation holds",
      "plain_english": "The company continues on its current trajectory — neither surprising positively nor negatively.",
      "what_to_watch": "Margin trends and competitive dynamics.",
      "upside": null,
      "risk_plain": "If the base case is already priced in, limited upside from here.",
      "survival_score": 0.6,
      "status": "MODERATE",
      "weighted_inconsistency": 2,
      "last_updated": "2026-02-16T06:49:06.276Z"
    },
    "N3": {
      "label": "Competitive Disruption",
      "description": "Pro Medicus faces headwinds; earnings or multiples compress",
      "plain_english": "This is the bear case — something goes wrong and the stock de-rates.",
      "what_to_watch": "Cost pressures, competitive threats, or macro headwinds.",
      "upside": null,
      "risk_plain": "Material downside if multiple risks crystallise simultaneously.",
      "survival_score": 0.3,
      "status": "LOW",
      "weighted_inconsistency": 4,
      "last_updated": "2026-02-16T06:49:06.276Z"
    },
    "N4": {
      "label": "AI Amplifies the Moat",
      "description": "A structural shift changes the investment case for Pro Medicus",
      "plain_english": "An external force — technology, regulation, or competition — fundamentally alters the business.",
      "what_to_watch": "Industry disruption signals and regulatory changes.",
      "upside": null,
      "risk_plain": "If disruption materialises, prior assumptions become invalid.",
      "survival_score": 0.15,
      "status": "LOW",
      "weighted_inconsistency": 5,
      "last_updated": "2026-02-16T06:49:06.276Z"
    }
  },
  "dominant": "N2",
  "confidence": "LOW",
  "alert_state": "NORMAL",
  "current_price": null,
  "big_picture": "Pro Medicus (ASX: PME) — coverage initiated. Full analysis pending.",
  "last_flip": null,
  "narrative_history": [],
  "evidence_items": [],
  "price_signals": [],
  "editorial_override": null,
  "price_history": [],
  "weighting": null,
  "three_layer_signal": {
    "company_signal": 34,
    "company_detail": {
      "method": "net_hypothesis_weights",
      "bull": 67,
      "bear": 33,
      "direction": "upside",
      "hypotheses": [
        {
          "title": "N1: US Expansion Accelerates",
          "direction": "upside",
          "weight": 37
        },
        {
          "title": "N2: Valuation Mean-Reversion",
          "direction": "downside",
          "weight": 21
        },
        {
          "title": "N3: Competitive Disruption",
          "direction": "downside",
          "weight": 12
        },
        {
          "title": "N4: AI Amplifies the Moat",
          "direction": "upside",
          "weight": 30
        }
      ],
      "computed_at": "2026-02-24T07:54:21.302Z"
    },
    "overall_sentiment": 34,
    "sentiment_label": "UPSIDE",
    "method": "company_only",
    "composite_computed_at": "2026-02-24T07:54:38.656Z",
    "macro_signal": 0,
    "sector_signal": 0,
    "tech_signal": 0,
    "external_weight": 0
  },
  "risk_skew": "UPSIDE"
}
